Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lumpi-ProVacInd
- Development stage
- Unknown
- Lead developer
- National Research Centre on Equines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Lumpi-ProVacInd is a live-attenuated homologous vaccine developed by Indian Immunologicals (IIL) in collaboration with the Indian Council of Agricultural Research (ICAR) - National Research Centre on Equines (NRCE) and the Indian Veterinary Research Institute (IVRI). It is specifically designed for the prevention of Lumpy Skin Disease (LSD) in cattle. The vaccine utilizes a weakened 'Ranchi' strain of the Lumpy Skin Disease Virus (LSDV) to stimulate a robust and protective immune response. Unlike heterologous goat pox vaccines previously used as an interim measure, Lumpi-ProVacInd provides homologous protection, which is considered superior for controlling LSD outbreaks. It is administered via subcutaneous injection and has been commercially launched to address the significant economic impact of LSD on the livestock and dairy industries.
- Brand names
- Lumpi-ProVacInd
- Other names
- Lumpy Skin Disease vaccineLSD vaccineLSDV vaccine
Beyond the preview
Go deeper on Lumpi-ProVacInd.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lumpi-ProVacInd.